Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Majid,Momeny

第一单位： Cancer Cell Signaling, Turku Center for Biotechnology, University of Turku and ÅboAkademi University, Turku, Finland.

作者： Majid,Momeny ^[1] ; Haniyeh,Eyvani ^[2] ; Farinaz,Barghi ^[2] ; Seyed H,Ghaffari ^[2] ; Sepehr,Javadikooshesh ^[3] ; Robab,Hassanvand Jamadi ^[2] ; Fatemeh,Esmaeili ^[2] ; Zivar,Alishahi ^[2] ; Azam,Zaghal ^[2] ; Davood,Bashash ^[4] ; Fazel S,Samani ^[5] ; Parisa,Ghaffari ^[2] ; Ahmad R,Dehpour ^[6] ; Seyyed M,Tavangar ^[7] ; Kamran,Alimoghaddam ^[8] ; Ardeshir,Ghavamzadeh ^[2]

作者单位： Cancer Cell Signaling, Turku Center for Biotechnology, University of Turku and ÅboAkademi University, Turku, Finland. ^[1] Hematology/Oncology and Stem Cell Transplantation Research Center. ^[2] Department of Medical Genetics, Shahid Beheshti University of Medical Sciences. ^[3] Department of Hematology and Blood Banking, Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences. ^[4] Department of Stem Cell and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. ^[5] Department of Pharmacology, School of Medicine. ^[6] Experimental Medicine Research Center, Tehran University of Medical Sciences. ^[7] Department of Pathology, Shariati Hospital. ^[8]